SynthesisFrontiers in immunology2025

Survival benefits of different immunotherapies for hepatocellular carcinoma: a meta-analysis highlighting age, gender, etiology, and tumor burden.

Ming-Cheng Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.